World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care (Q34578945)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1 reference

Europe PubMed Central

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

0 references

biological psychiatry

1 reference

based on heuristic

inferred from title

Hans-Jürgen Möller

7

object named as

Hans-Jürgen Möller

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Peter C. Whybrow

4

object named as

Peter C Whybrow

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

3

object named as

Andrea Pfennig

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1

object named as

Michael Bauer

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

2

object named as

Tom Bschor

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

5

object named as

Jules Angst

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Marcio Versiani

6

object named as

Marcio Versiani

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

author name string

WFSBP Task Force on Unipolar Depressive Disorders

8

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

publication date

1 January 2007

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

World Journal of Biological Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

67-104

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Is dose escalation of antidepressants a rational strategy after a medium-dose treatment has failed? A systematic review

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Psychopathologic correlates of suicidal ideation in major depressive outpatients: is it all due to unrecognized (bipolar) depressive mixed states?

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Does thyroid supplementation accelerate tricyclic antidepressant response? A review and meta-analysis of the literature

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Safety of antidepressant drugs in the patient with cardiac disease: a review of the literature

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines. British Association for Psychopharmacology

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Meta-analytical studies on new antidepressants.

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Toward a re-definition of subthreshold bipolarity: epidemiology and proposed criteria for bipolar-II, minor bipolar disorders and hypomania.

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

The HCL-32: towards a self-assessment tool for hypomanic symptoms in outpatients

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Suicide in psychiatric patients: risk and prevention

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Triiodothyronine augmentation in the treatment of refractory depression. A meta-analysis

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

A comparative study of nonspecific depressive symptoms and minor depression regarding functional impairment and associated characteristics in primary care

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Evidence that the SSRI dose response in treating major depression should be reassessed: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Guideline for the management of late-life depression in primary care.

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Lithium augmentation in treatment-resistant depression: meta-analysis of placebo-controlled studies

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Treatment of refractory depression with high-dose thyroxine.

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Double-blind, placebo-controlled trial of the use of lithium to augment antidepressant medication in continuation treatment of unipolar major depression

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and continuation treatment of major depressive disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 2: Maintenance treatment of major depressive disorder and treatment of chronic depressive disorders and subthre

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Supraphysiological doses of levothyroxine alter regional cerebral metabolism and improve mood in bipolar depression

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

An Inventory for Measuring Depression

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Summary of the practice parameters for the assessment and treatment of children and adolescents with depressive disorders. American Academy of Child and Adolescent Psychiatry.

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Comparison of sertraline and nortriptyline in the treatment of major depressive disorder in late life.

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Affective Disorders and Suicide Risk: A Reexamination

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Exercise and the treatment of clinical depression in adults: recent findings and future directions

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Sertraline and/or interpersonal psychotherapy for patients with dysthymic disorder in primary care: 6-month comparison with longitudinal 2-year follow-up of effectiveness and costs

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

How long should the lithium augmentation strategy be maintained? A 1-year follow-up of a placebo-controlled study in unipolar refractory major depression.

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Psychodynamic psychotherapy and clomipramine in the treatment of major depression

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

The use of psychotropic medications during breast-feeding

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Relapse into mania or depression following lithium discontinuation: a 7-year follow-up

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Long-term lithium and mortality

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, fluoxetine, and venlafaxine in treatment-resistant depression

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Lithium and suicidal behavior in major affective disorder: a case-control study.

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

“Dopamine-Dependent” Side Effects of Selective Serotonin Reuptake Inhibitors

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Mood stabilizers in the prevention of recurrent affective disorders: a meta-analysis

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Maintenance strategies for unipolar depression: an observational study of levels of treatment and recurrence.

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

A prospective trial of bupropion SR augmentation of partial and non-responders to serotonergic antidepressants

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Combining psychotherapy and antidepressants in the treatment of depression

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Psychotherapy alone and combined with pharmacotherapy in the treatment of depression

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

An open treatment trial of venlafaxine for elderly patients with dysthymic disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Benefits from aerobic exercise in patients with major depression: a pilot study

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

A meta-analysis of the efficacy of cognitive therapy for depression

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

To combine or not to combine? A literature review of antidepressant combination therapy

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Systematic review and guide to selection of selective serotonin reuptake inhibitors

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Comparison of extended-release venlafaxine, selective serotonin reuptake inhibitors, and tricyclic antidepressants in the treatment of depression: a meta-analysis of randomized controlled trials.

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

National Institute of Mental Health Treatment of Depression Collaborative Research Program

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression.

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study.

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Switching to reboxetine: an efficacy and safety study in patients with major depressive disorder unresponsive to fluoxetine

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

The role of monoamine oxidase inhibitors in current psychiatric practice

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Masked depression: its interrelations with somatization, hypochondriasis and conversion

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence.

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Critical review of tricyclic antidepressant use in children and adolescents

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Vagus nerve stimulation: a new tool for brain research and therapy.

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression.

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Direct comparison of total sleep deprivation and late partial sleep deprivation in the treatment of major depression.

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

A meta-analysis of the effects of cognitive therapy in depressed patients

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

The Efficacy of Light Therapy in the Treatment of Mood Disorders: A Review and Meta-Analysis of the Evidence

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Suicide risk in bipolar disorder during treatment with lithium and divalproex

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: Treatment of bipolar depression

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of Mania

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: maintenance treatment

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Use of sertraline, paroxetine and fluvoxamine by nursing women

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Pharmacokinetics of selective serotonin reuptake inhibitors

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Clinical importance of long-term antidepressant treatment

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Discontinuation rates of SSRIs and tricyclic antidepressants: a meta-analysis and investigation of heterogeneity

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Major depressive disorder in a population of urban, African-American young adults: prevalence, correlates, comorbidity and unmet mental health service need

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Impact of medical comorbid disease on antidepressant treatment of major depressive disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Drug interactions with St. John's Wort (Hypericum perforatum): a review of the clinical evidence

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Preventing recurrent depression using cognitive therapy with and without a continuation phase: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Antidepressants and the risk of suicidal behaviors

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Integration of Care: Integrating Psychotherapy and Pharmacotherapy to Improve Outcomes Among Patients With Mood Disorders

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders.

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Epidemiological findings of seasonal changes in mood and behavior. A telephone survey of Montgomery County, Maryland.

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Efficacy of antidepressants in the treatment of severe depression: the place of mirtazapine

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Approaches to the management of depression in old age.

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Managing depression and anxiety in the elderly patient.

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Placebo-controlled trial of lithium augmentation of fluoxetine and lofepramine.

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Reboxetine versus imipramine in the treatment of elderly patients with depressive disorders: a double-blind randomised trial

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Rationale and options for the long-term treatment of depression

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression.

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Placebo-controlled trial of agomelatine in the treatment of major depressive disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: an analysis of the Food and Drug Administration database

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

St. John's wort for depression: a meta-analysis of well-defined clinical trials

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Dysthymia and chronic depression: introduction, classification, risk factors, and course

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Cognitive-behavioral analysis system of psychotherapy as a maintenance treatment for chronic depression.

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

The course, morbidity, and costs of depression

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo-controlled study of maintenance therapy

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

A randomised, controlled study on the effects of a short-term endurance training programme in patients with major depression

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Pharmacotherapy for chronic depression

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Sleep deprivation therapy

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Two roads to rapid eye movement latency

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Lithium-antidepressant combinations in the treatment of depressed, physically ill geriatric patients.

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Efficacy and tolerability of reboxetine compared with citalopram: a double-blind study in patients with major depressive disorder.

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

PubMed Central: creating an Aladdin's cave of ideas

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

A comparison of open treatment of seasonal major and minor depression with light therapy.

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Treatment strategies in patients with major depression not responding to first-line sertraline treatment. A randomised study of extended duration of treatment, dose increase or mianserin augmentation

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Meta-analysis of the reversible inhibitors of monoamine oxidase type A moclobemide and brofaromine for the treatment of depression

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Selective serotonin reuptake inhibitors: a review of efficacy and tolerability in depression

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

The clinical effects of lithium discontinuation: the debate continues

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Vagus nerve stimulation (VNS) for major depressive episodes: one year outcomes.

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Repetitive transcranial magnetic stimulation for the treatment of depression. Systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Atypical antipsychotics in the treatment of affective symptoms: a review

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Treatment for chronic depression using Cognitive Behavioral Analysis System of Psychotherapy (CBASP).

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Treatments of depression and the functional capacity to work.

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Is there evidence for negative effects of antidepressants on suicidality in depressive patients? A systematic review

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Improving the chance of recovery from the short- and long-term consequences of depression.

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

A New Depression Scale Designed to be Sensitive to Change

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Antidepressant medications: a review of the evidence for drug-induced sexual dysfunction

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

The effect of long-term lithium treatment on the mortality of patients with manic-depressive and schizoaffective illness

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Mortality during initial and during later lithium treatment. A collaborative study by the International Group for the Study of Lithium-treated Patients.

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

The antisuicidal and mortality-reducing effect of lithium prophylaxis: consequences for guidelines in clinical psychiatry.

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Spotlight on sertraline in the management of major depressive disorder in elderly patients

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Treatment-resistant depression in late life

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Randomised controlled trial of problem solving treatment, antidepressant medication, and combined treatment for major depression in primary care

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Incidence of major depression: prediction from subthreshold categories in the Stirling County Study

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Neurodevelopment of children exposed in utero to antidepressant drugs

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Efficacy of ECT in depression: a meta-analytic review

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Quality of life assessments in major depressive disorder: a review of the literature

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Which antidepressants flick the switch?

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Continuation cognitive-behavioural therapy maintains attributional style improvement in depressed patients responding acutely to fluoxetine.

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Medication options in the treatment of treatment-resistant depression.

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Continuation drug therapy for major depressive episodes: how long should it be maintained?

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Cyclic antidepressants and the risk of sudden cardiac death

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

The de facto US mental and addictive disorders service system. Epidemiologic catchment area prospective 1-year prevalence rates of disorders and services.

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Optimal length of continuation therapy in depression: a prospective assessment during long-term fluoxetine treatment.

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

A meta-analysis of the effects of venlafaxine on anxiety associated with depression.

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

How to preserve the antidepressive effect of sleep deprivation: A comparison of sleep phase advance and sleep phase delay

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

A comparison of paroxetine and amisulpride in the treatment of dysthymic disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Antidepressant pharmacotherapy in the treatment of depression in the very old: a randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Seasonal affective disorder. A description of the syndrome and preliminary findings with light therapy

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Switching Antidepressants After a First Selective Serotonin Reuptake Inhibitor in Major Depressive Disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Effects of fluoxetine versus bright light in the treatment of seasonal affective disorder.

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial.

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Optimal length of antidepressant trials in late-life depression

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Selective serotonin reuptake inhibitors and myocardial infarction

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Lithium prophylaxis: myths and realities

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Forty years of lithium treatment

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

A novel augmentation strategy for treating resistant major depression

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Initial antidepressant choice in primary care. Effectiveness and cost of fluoxetine vs tricyclic antidepressants

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Suicide risk during antidepressant treatment.

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Lithium treatment and prophylaxis in unipolar depression: a meta-analysis

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

The pharmacological treatment of delusional depression

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Differential pharmacokinetics of lithium in elderly patients

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Efficacy of venlafaxine in geriatric depression

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Prevalence of depression and its treatment in an elderly population: the Cache County study.

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

A systematic review of antidepressant placebo-controlled trials for geriatric depression: limitations of current data and directions for the future

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Double-blind switch study of imipramine or sertraline treatment of antidepressant-resistant chronic depression

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Lower suicide risk with long-term lithium treatment in major affective illness: a meta-analysis

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Medication augmentation after the failure of SSRIs for depression.

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Care for depression in HMO patients aged 65 and older

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Benzodiazepine use among depressed patients treated in mental health settings

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Discontinuing antidepressant treatment in major depression

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

The burden of major depression avoidable by longer-term treatment strategies.

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

A longitudinal population-based study of treated and untreated major depression

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Prevalence and incidence studies of mood disorders: a systematic review of the literature

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

The epidemiology of dysthymia in five communities: rates, risks, comorbidity, and treatment

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Detection of depressive disorder for patients receiving prepaid or fee-for-service care. Results from the Medical Outcomes Study

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Antidepressants and sexual dysfunction.

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Time course of response to antidepressants in late-life major depression: therapeutic implications

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Patterns of response to repeated total sleep deprivations in depression

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Pharmacological treatment for unipolar psychotic depression: Systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Cardiovascular effects of therapeutic doses of tricyclic antidepressants in children and adolescents

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

A comparison of side effects of selective serotonin reuptake inhibitors and tricyclic antidepressants in older depressed patients: a meta-analysis

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Sleep deprivation in depression: what do we know, where do we go?

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Antidepressant treatment during breast-feeding

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Pharmacologic treatment of depression during pregnancy

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Aripiprazole as an augmentor of selective serotonin reuptake inhibitors in depression and anxiety disorder patients

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

The biological basis of an antidepressant response to sleep deprivation and relapse: review and hypothesis

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

A systematic review of the mortality of depression

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

The quality of care for depressive and anxiety disorders in the United States.

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Lithium augmentation in depressive patients not responding to selective serotonin reuptake inhibitors

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Cognitive Therapy and Pharmacotherapy for Depression

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Bright light therapy stabilizes the antidepressant effect of partial sleep deprivation

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Prevalence of seasonal affective disorder at four latitudes

1 reference

https://api.crossref.org/works/10.1080%2F15622970701227829

21 January 2018

Identifiers

10.1080/15622970701227829

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34578945&oldid=1861317812"